Web Directory Search Engine

Gene Therapy Directory Resources



  

  

Submit Link  | Bookmarks | Contact Us

Web Directory

Web Directory
 

Submit URL Gene Therapy  

 
Gene Therapy News


Brain cells called astrocytes undergo reorganization and may engulf attacking T cells (EurekAlert!)
( Cedars-Sinai Medical Center ) When virally infected cells in the brain called astrocytes come in contact with antiviral T cells of the immune system, they undergo a unique series of changes that dramatically reorganize their shape and function, according to researchers at the Board of Governors Gene Therapeutics Research Institute at Cedars-Sinai Medical Center. Intriguingly, the new data ...
   

Brain Cells Called Astrocytes Undergo Reorganization and May Engulf Attacking T Cells (Newswise)
When virally infected cells in the brain called astrocytes come in contact with anti-viral T cells of the immune system, they undergo a unique series of changes that dramatically reorganize their shape and function, according to researchers at the Board of Governors Gene Therapeutics Research Institute at Cedars-Sinai Medical Center. Intriguingly, the new data indicate that astrocytes may defend ...
   

Brain Cells Called Astrocytes Undergo Reorganization And May Engulf Attacking T Cells (Medical News Today)
When virally infected cells in the brain called astrocytes come in contact with anti-viral T cells of the immune system, they undergo a unique series of changes that dramatically reorganize their shape and function, according to researchers at the Board of Governors Gene Therapeutics Research Institute at Cedars-Sinai Medical Center.
   

Newsmaker: Gina Marie DiFranco (Pittsburgh Tribune-Review)
Gina Marie DiFranco won the Mary McMillan Scholarship, given by the American Physical Therapy Association.
   

EMEA accepts to review Introgen's MAA for Advexin (PharmaBiz)
Introgen Therapeutics, Inc, a developer of targeted molecular therapies for cancer, and its subsidiary Gendux Molecular Limited, announced that the European Medicines Agency (EMEA) has accepted for review the company's Marketing Authorization Application (MAA) for Advexin (p53 tumour suppressor therapy) for the treatment of recurrent, refractory squamous cell carcinoma of the head and neck.
   

Main Directory

Arts and Entertainment Directory Arts and Entertainment

Business and Industry Directory Business and Industry

Computers Directory Computers

Daily Lifestyle Directory Daily Lifestyle

Health and Fitness Directory Health and Fitness

Internet Directory Internet

Kids and Teens Directory Kids and Teens

Shopping Directory Shopping

Society and Culture Directory Society and Culture

Sports Directory Sports

Popular Categories

Web DirectoriesWeb Directories

Paid DirectoriesPaid Directories

Business & IndustryBusiness & Industry

ComputersComputers

InternetInternet

Arts & EntertainmentArts & Entertainment

ShoppingShopping

Real EstateReal Estate

SportsSports

Health & FitnessHealth & Fitness